Evidence map›Paper›PMID 35316134›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

RibU is an essential determinant of

Rafael Rivera-Lugo, Samuel H Light, Nicholas E Garelis, Daniel A Portnoy

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Avoidance of MAIT cells is an essential determinant ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. ReprogrammingmBio · 2026
    Article
  3. Infection and immunity · 2025
    Article
  4. Article
  5. Infection and immunity · 2024
    Article
  6. Article
  7. Article
  8. Infection and immunity · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rafael Rivera-LugoDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.ORCID 0000-0002-2346-2297
Samuel H LightDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
Nicholas E GarelisDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
Daniel A PortnoyDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
University of California, Berkeley · US

Funding

The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PORTNOY, DANIEL A · 2004 to 2025
$45.5M
Listeria Hemolysis and Escape From a VacuoleR01AI027655 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DANIEL A PORTNOY · 1993 to 2026
$10.1M
Electrogenic metabolism in host-associated microbial communities andpathogenesisK22AI144031 · NIAID · UNIVERSITY OF CHICAGO · PI LIGHT, SAMUEL · 2020 to 2021
$268k
Characterizing the role of an extracellular electron transport chain in Listeria monocytogenes virulence factor expression and metabolismF32AI136389 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI LIGHT, SAMUEL · 2018 to 2019
$131k
NIAID NIH HHS F32 AI136389NIAID NIH HHS K22 AI144031NIAID NIH HHS P01 AI063302NIAID NIH HHS R01 AI027655
6 · The paper itself

Abstract

Flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are essential riboflavin-derived cofactors involved in a myriad of redox reactions across all forms of life. Nevertheless, the basis of flavin acquisition strategies by riboflavin auxotrophic pathogens remains poorly defined. In this study, we examined how the facultative intracellular pathogen Listeria monocytogenes, a riboflavin auxotroph, acquires flavins during infection. A L. monocytogenes mutant lacking the putative riboflavin transporter (RibU) was completely avirulent in mice but had no detectable growth defect in nutrient-rich media. However, unlike wild type, the RibU mutant was unable to grow in defined media supplemented with FMN or FAD or to replicate in macrophages starved for riboflavin. Consistent with RibU functioning to scavenge FMN and FAD inside host cells, a mutant unable to convert riboflavin to FMN or FAD retained virulence and grew in cultured macrophages and in spleens and livers of infected mice. However, this FMN- and FAD-requiring strain was unable to grow in the gallbladder or intestines, where L. monocytogenes normally grows extracellularly, suggesting that these sites do not contain sufficient flavin cofactors to promote replication. Thus, by deleting genes required to synthesize FMN and FAD, we converted L. monocytogenes from a facultative to an obligate intracellular pathogen. Collectively, these data indicate that L. monocytogenes requires riboflavin to grow extracellularly in vivo but scavenges FMN and FAD to grow in host cells.

Indexed as

Bacterial ProteinsFlavin-Adenine DinucleotideFlavin MononucleotideListeria monocytogenesMembrane Transport ProteinsRiboflavinBacterial ProteinsFlavin-Adenine DinucleotideFlavin MononucleotideMembrane Transport ProteinsRiboflavinbacteriainflammasomeintracellular pathogensmacrophageriboflavin

Identifiers

PMID35316134
PMCPMC9060500
OpenAlexW4221042720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.